- Home
- GRWG vs ALGS Comparison
GRWG vs ALGS Comparison
Compare GRWG & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- ALGS
- Stock Information
- Founded
- GRWG 2008
- ALGS 2018
- Country
- GRWG United States
- ALGS United States
- Employees
- GRWG N/A
- ALGS N/A
- Industry
- GRWG RETAIL: Building Materials
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- ALGS Health Care
- Exchange
- GRWG Nasdaq
- ALGS Nasdaq
- Market Cap
- GRWG 59.4M
- ALGS 53.0M
- IPO Year
- GRWG N/A
- ALGS 2020
- Fundamental
- Price
- GRWG $1.10
- ALGS $9.13
- Analyst Decision
- GRWG Buy
- ALGS Strong Buy
- Analyst Count
- GRWG 4
- ALGS 1
- Target Price
- GRWG $2.38
- ALGS $70.00
- AVG Volume (30 Days)
- GRWG 856.9K
- ALGS 85.7K
- Earning Date
- GRWG 08-07-2025
- ALGS 08-05-2025
- Dividend Yield
- GRWG N/A
- ALGS N/A
- EPS Growth
- GRWG N/A
- ALGS N/A
- EPS
- GRWG N/A
- ALGS N/A
- Revenue
- GRWG $176,681,000.00
- ALGS $3,270,000.00
- Revenue This Year
- GRWG N/A
- ALGS N/A
- Revenue Next Year
- GRWG N/A
- ALGS $51.55
- P/E Ratio
- GRWG N/A
- ALGS N/A
- Revenue Growth
- GRWG N/A
- ALGS N/A
- 52 Week Low
- GRWG $0.82
- ALGS $3.76
- 52 Week High
- GRWG $2.47
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- GRWG 53.70
- ALGS 59.79
- Support Level
- GRWG $0.96
- ALGS $8.18
- Resistance Level
- GRWG $1.21
- ALGS $9.44
- Average True Range (ATR)
- GRWG 0.06
- ALGS 0.71
- MACD
- GRWG 0.02
- ALGS 0.01
- Stochastic Oscillator
- GRWG 56.00
- ALGS 65.95
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.